TY - JOUR
T1 - A two-arm non-randomised trial of MedEx IMPACT
T2 - a community-based, physical activity behaviour change intervention for survivors of cancer
AU - Cantwell, Mairéad
AU - Moyna, Niall
AU - McCaffrey, Noel
AU - Skelly, Fiona
AU - Loughney, Lisa
AU - Woods, Catherine
AU - Walsh, Deirdre
AU - Dowd, Kieran
AU - McCarren, Andrew
AU - Kehoe, Bróna
N1 - Publisher Copyright:
© 2024, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2024/2
Y1 - 2024/2
N2 - Purpose: This two-arm non-randomised trial examined the short- and long-term effects of a usual care (UC) community-based exercise programme (MedEx Move On (MMO)), and UC combined with a physical activity (PA) behaviour change (BC) intervention (MedEx IMproved PA after Cancer Treatement (MedEx IMPACT)) on PA levels, cardiorespiratory fitness (CRF) and quality of life (QoL) among survivors of cancer. Methods: Cancer survivors referred to MMO were recruited (n = 191; mean age (± SD) 56 (± 10y), 73% female). Eighty-seven participants were assigned to UC, and 104 participants were assigned to the MedEx IMPACT intervention group (MI). UC and MI both received twice-weekly supervised exercise classes for 12-weeks. MI also received an independent PA programme, 4 PA information sessions and a 1:1 exercise consultation during the 12-week programme. Assessments of physical and psycho-social health, including 6-day accelerometry, the 6-min time trial and the Functional Assessment of Cancer Therapy-General QoL questionnaire, were conducted at baseline (T1), post-intervention (T2) and 3 months following programme completion (T3). Results: Linear mixed-model analyses of variance demonstrated significant main effects for time for both groups from T1 to T2 with increases in objectively measured daily steps (p < 0.05), CRF (p <.001) and QoL (p <.01), which were maintained for CRF (p <.001) at T3. MI participants also maintained increases achieved at T2, in steps and QoL, at T3 (p < 0.01). Conclusion: Twelve weeks of twice-weekly supervised exercise was effective in increasing PA, CRF and QoL among survivors of cancer. MI resulted in the maintenance of all improvements achieved 3 months following programme completion.
AB - Purpose: This two-arm non-randomised trial examined the short- and long-term effects of a usual care (UC) community-based exercise programme (MedEx Move On (MMO)), and UC combined with a physical activity (PA) behaviour change (BC) intervention (MedEx IMproved PA after Cancer Treatement (MedEx IMPACT)) on PA levels, cardiorespiratory fitness (CRF) and quality of life (QoL) among survivors of cancer. Methods: Cancer survivors referred to MMO were recruited (n = 191; mean age (± SD) 56 (± 10y), 73% female). Eighty-seven participants were assigned to UC, and 104 participants were assigned to the MedEx IMPACT intervention group (MI). UC and MI both received twice-weekly supervised exercise classes for 12-weeks. MI also received an independent PA programme, 4 PA information sessions and a 1:1 exercise consultation during the 12-week programme. Assessments of physical and psycho-social health, including 6-day accelerometry, the 6-min time trial and the Functional Assessment of Cancer Therapy-General QoL questionnaire, were conducted at baseline (T1), post-intervention (T2) and 3 months following programme completion (T3). Results: Linear mixed-model analyses of variance demonstrated significant main effects for time for both groups from T1 to T2 with increases in objectively measured daily steps (p < 0.05), CRF (p <.001) and QoL (p <.01), which were maintained for CRF (p <.001) at T3. MI participants also maintained increases achieved at T2, in steps and QoL, at T3 (p < 0.01). Conclusion: Twelve weeks of twice-weekly supervised exercise was effective in increasing PA, CRF and QoL among survivors of cancer. MI resulted in the maintenance of all improvements achieved 3 months following programme completion.
KW - Behaviour change
KW - Cancer
KW - Physical activity
UR - http://www.scopus.com/inward/record.url?scp=85181872115&partnerID=8YFLogxK
U2 - 10.1007/s00520-023-08263-8
DO - 10.1007/s00520-023-08263-8
M3 - Article
AN - SCOPUS:85181872115
SN - 0941-4355
VL - 32
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 2
M1 - 95
ER -